Grant ID RP240537
Awarded On February 19, 2025
Title Cancer Agent Target Discovery and Aptamer Development (CATDAD) Core
Program Academic Research
Award Mechanism Core Facility Support Awards
Institution/Organization Baylor Research Institute
Principal Investigator/Program Director Erxi Wu
Cancer Sites All Sites
Contracted Amount $2,999,989*

*Pending contract negotiation

Lay Summary

Many anticancer agents function by targeting specific molecules involved in the proliferation and survival of cancer cells, while sparing normal cells. However, the unknown binding targets or unintended off-targets of these drugs often result in less effective treatments and lower patient survival rates. This knowledge gap also hinders the advancement of more efficacious cancer therapies. In response to this challenge, Dr. Wu's team has innovated in identifying the binding targets of anticancer drugs, facilitating a deeper understanding of their mechanisms. Moreover, they have formulated cost-effective, safe methodologies for screening aptamer-based therapeutics for cancer treatment. To sup...

Read More